Cross-reactive neutralizing activity in HIV-1 infected injecting drug users

Ítems similars

• P04-50 LB. Prevalence of cross-reactive HIV-1 neutralizing activity in HIV-1 infected patients with rapid or slow disease progression
  per: van Gils, MJ, et al.
  Publicat: (2009)
• HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
  per: van den Kerkhof, TL, et al.
  Publicat: (2012)
• HIV-1 envelope characteristics that coincide with the development of cross-reactive neutralizing activity in HIV-1 infected patients
  per: van den Kerkhof, Tom, et al.
  Publicat: (2011)
• Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users
  per: Zelda EULER, et al.
  Publicat: (2019-04-01)
• Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users
  per: EULER, Zelda, et al.
  Publicat: (2019)